These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 6259599)

  • 21. [Pharmacokinetics of cefamandole in rabbits].
    Klimova VS; Bobrov VI; Nazarova OI; Skala LZ; Iakovlev VP
    Antibiotiki; 1982 Dec; 27(12):34-8. PubMed ID: 7165292
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interference of cephalosporins and cefoxitin with serum creatinine determination.
    Hyneck ML; Berardi RR; Johnson RM
    Am J Hosp Pharm; 1981 Sep; 38(9):1348-52. PubMed ID: 7282720
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative tissue distribution of ceforanide, cefazolin, and cefamandole in rats.
    Lee FH; Smyth RD; Van Harken DR
    Antimicrob Agents Chemother; 1981 Apr; 19(4):625-7. PubMed ID: 7247385
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of cefamandole in osseous tissue.
    Lunke RJ; Fitzgerald RH; Washington JA
    Antimicrob Agents Chemother; 1981 May; 19(5):851-8. PubMed ID: 7294769
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A study of the transplacental passage of cefotaxime (author's transl)].
    Pierre J; Bergogne-Berezin E; Ravina J; Vernant D
    Nouv Presse Med; 1981 Feb; 10(8):587-9. PubMed ID: 6259598
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Penetration activities of cefoxitin into different human tissues. An experimental study (author's transl)].
    Plaue R; Müller O; Jenne V; Fabricius K; Bethke RO
    Med Klin; 1979 Mar; 74(13):481-7. PubMed ID: 431475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies on the pharmacokinetics of cefoxitin, cefuroxime, cephaloridine and cephalothin using subcutaneous tissue cages.
    Rylander M; Holm SE; Norrby R; Brorson JE
    Scand J Infect Dis Suppl; 1978; (13):52-7. PubMed ID: 278147
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparative study of cefotaxime serum and lung concentrations in 6 patients with thoracotomy (author's transl)].
    Pous J; Peltier M; Berthoumieu C; Monnier J
    Nouv Presse Med; 1981 Feb; 10(8):585-6. PubMed ID: 6259597
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of beta-lactamase stability, penetration, and target affinity on the activity of cefazolin, cefamandole, cefoxitin, and cefuroxime.
    Harper PB
    Clin Ther; 1984; 6(3):310-24. PubMed ID: 6609771
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative study of single-dose cefotaxime and multiple doses of cefoxitin and cefazolin as prophylaxis in gynecologic surgery.
    Campillo F; Rubio JM
    Am J Surg; 1992 Oct; 164(4A Suppl):12S-15S. PubMed ID: 1443353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Diffusion of cefotaxime in different tissues of the urogenital tract (author's transl)].
    Schalhäuser K; Adam D
    Infection; 1980; 8 Suppl 3():S 327-9. PubMed ID: 6250982
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Excretion of cefamandole, cefazolin, and cephalothin into T-tube bile.
    Ratzan KR; Baker HB; Lauredo I
    Antimicrob Agents Chemother; 1978 Jun; 13(6):985-7. PubMed ID: 677864
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Availability of cefotaxime. Pharmacokinetic studies on the distribution in central and various peripheral compartments (author's transl)].
    Wittmann DH; Schassan HH; Welter J; Seidel H
    MMW Munch Med Wochenschr; 1980 Apr; 122(17):637-41. PubMed ID: 6248774
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of furosemide on extravascular diffusion, protein binding and urinary excretion of cephalosporins and aminoglycosides in rabbits.
    Carbon C; Contrepois A; Vigneron AM; Lamotte-Barrillon S
    J Pharmacol Exp Ther; 1980 Jun; 213(3):600-6. PubMed ID: 7205620
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stability of cefamandole nafate and cefoxitin sodium solutions.
    Das Gupta V; Stewart KR
    Am J Hosp Pharm; 1981 Jun; 38(6):875-9. PubMed ID: 7246563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pharmacokinetics and tolerance of Cefazedone compared with Cefazoline (author's transl)].
    Hitzenberger G; Jaschek I
    Wien Med Wochenschr; 1980 Feb; 130(3):135-42. PubMed ID: 7368759
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relevance of protein binding to cephalosporin antimicrobial activity in vivo.
    Mays B; Short L; Hershman MJ; Cheadle WG
    Chemotherapy; 1990; 36(4):254-8. PubMed ID: 2253496
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative pharmacokinetics of ceforanide (BL-S786R) and cefazolin in laboratory animals and humans.
    Lee FH; Pfeffer M; Van Harken DR; Smyth RD; Hottendorf GH
    Antimicrob Agents Chemother; 1980 Feb; 17(2):188-92. PubMed ID: 7387141
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protein binding and concentrations of cephaloridine and cefazolin in serum and interstitial fluid of dogs.
    Waterman NG; Raff MJ; Scharfenberger L; Barnwell PA
    J Infect Dis; 1976 Jun; 133(6):642-7. PubMed ID: 932492
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the pharmacokinetics of cefamandole and other cephalosporin compounds.
    Neu HC
    J Infect Dis; 1978 May; 137 Suppl():S80-S87. PubMed ID: 650006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.